Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The PRISM Study: LMWH vs UFH for Perioperative Bridging
NCT00253396Phase 4Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Oct 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in thromboembolism, sponsored by Hamilton Health Sciences. Started Oct 2005; status: completed.
02
Drugs
enoxaparin
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT00253396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00253396.